Microbial/host interactions in health and disease: Who controls the cytokine network?

Immunopharmacology

Volumn 35, Issue 1, 1996, Pages 1-21

  Henderson, Brian ^a   Poole, Stephen ^a   Wilson, Michael ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

bacteria; cytokines; immunity; inflammation; networks; viruses

Indexed keywords

ANTIINFLAMMATORY AGENT; BACTERIAL TOXIN; CD14 ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

BACTERIUM; EUKARYOTIC CELL; GENE DELETION; HEALTH; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; IMMUNITY; INFECTION; INFLAMMATION; MEDIATOR; MICROFLORA; MICROORGANISM; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROKARYOTE; REGULATORY MECHANISM; REVIEW; SEPTIC SHOCK; VIRUS;

EID: 0030272902     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00144-0     Document Type: Review

References (126)

1. Alcami, A. and Smith, G.L., 1992. A soluble receptor for interleukin-1β encoded by vaccinia virus: A novel mechanism for virus modulation of the host response to infection. Cell, 71: 153-167.
2. Atkins, E., 1989. Fever: Historical aspects. In: R. Bomford and B. Henderson (Eds.), Interleukin-1: Inflammation and Disease. Elsevier, Amsterdam, pp. 3-15.
3. Autenrieth, I.B. and Heesemann, J., 1992. In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice. Med. Microbiol. Immunol., 181: 333-338.
4. Beuscher, H.U., Rodel, F., Forsberg, A. and Rollinghoff, M., 1995. Bacterial evasion of host immune defence: Yersinia enterocolitica encodes a suppressor factor for tumor necrosis factor alpha expression. Infect. Immun., 63: 1270-1277.
5. Bhakdi, S., Muhly, M., Korom, S. and Hugo, F., 1989. Release of interleukin-1 β associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect. Immun., 57: 3512-3519.
6. Bhakdi, S., Muhly, M., Korom, S. and Schmidt, G., 1990. Effects of Escherichia coli hemolysin on human monocytes: Cytocidal action and stimulation of interleukin-1 release. J. Clin. Invest., 85: 1746-1753.
7. Bone, R.C., 1993. Gram-negative sepsis: A dilemma of modern medicine. Clin. Microbiol. Rev., 6: 57-68.
8. Bone, R.C., 1994. Gram positive organisms and sepsis. Arch. Intern. Med., 154: 26-34.
9. Barton, B.E., Shortall, J. and Jackson, J.V., 1996. Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infect. Immun., 64: 714-718.
10. Chernoff, A.E., Granowitz, E.V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J.B., Kennedy, J.S., Rabson, A.R., Wolff, S.M. and Dinarello, C.A., 1995. A randomized, controlled trial of IL-10 in humans. J. Immunol., 154: 5492-5499.
11. Chua, T.P., Smith, C.E., Reith, R.W. and Williamsom, J.D., 1990. Inflammatory responses and the generation of chemoattractant activity in cowpox virus-infected tissues. Immunology, 69: 202-208.
12. Cook, D.N., Beck, M.A., Coffman, T.M., Kirby, S.L., Sheridan, J.F., Pragnell, I.B. and Smithies, O., 1995. Requirement for MIP-1α for an inflammatory response to viral infection. Science, 269: 1583-1585.
13. Cooper, G.M., 1995. Oncogenes, 2nd Ed. Jones and Bartlett, Boston.
14. Dahl, K.E., Shiratsuchi, H., Hamilton, B.D., Ellner, J.J. and Toossi, Z., 1996. Selective induction of transforming growth factor β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect. Immun., 64: 399-405.
15. Delude, R.L., Savedra, R., Zhao, H., Thieringer, R., Yamamoto, S., Fenton, M.J. and Golenbock, D.T., 1995. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA, 92: 9288-9292.
16. Denis, M., 1991. Growth of Mycobacterium avium in human monocytes: Identification of cytokines which reduce and enhance intracellular microbial growth. Eur. J. Immunol., 21: 391-395.
17. Denis, M. and Gregg, E.O., 1990. Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages. Immunology, 71: 139-141.
18. Denis, M., Campbell, D. and Gregg, E.O., 1991. Interleukin-2 and granulocyte-macrophage colony-stimulating factor stimulate growth of a virulent strain of Escherichia coli. Infect. Immun., 59: 1853-1856.
19. Dinarello, C.A., 1989. Was the original endogenous pyrogen interleukin-1? In: R. Bomford and B. Henderson (Eds.), Interleukin-1: Inflammation and Disease. Elsevier, Amsterdam, pp. 17-28.
20. Dinarello, C.A., 1994. Interleukin-1. Adv. Pharmacol., 25: 21-51.
21. Eckmann, L., Kagnoff, M.F. and Fierer, J., 1995. Intestinal epithelial cells as watchdogs for the natural immune system. Trends Microbiol., 3: 118-120.
22. Espevik, T., Otterlei, M., Skjak-Braek, G., Ryan, L., Wright, S.D. and Sundan, A., 1993. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol., 23: 255-261.
23. Feingold, K.R., Funk, J.L., Moser, A.H., Shigenaga, J.K., Rapp, J.H. and Grunfeld, C., 1995. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect. Immun., 63: 2041-2046.
24. Fenton, M.J. and Vermeulen, M.W., 1996. Minireview: Immunopathology of tuberculosis: Roles of macrophages and monocytes. Infect. Immun., 64: 683-690.
25. Flegel, W.A., Muller, F., Daubener, W., Fisher, H-G., Hadding, U. and Northoff, H., 1991. Cytokine response by human monocytes to Clostridium difficle toxin A and toxin B. Infect. Immun., 59: 3659-3666.
26. Fletcher, J., Reddi, K., Poole, S., Nair, S., Henderson, B. and Wilson, M., 1996. Interactions between periodontopathic bacteria and cytokines. J. Periodontol., in press.
27. Frederickson, T.N., Sechler, J.M., Palumbo, G.J., Albert, J., Khairallah, L.H. and Buller, R.M., 1992. Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo. Virology, 187: 693-704.
28. Frey, E.A., Miller, D.A., Jahr, T.G., Sundan, A., Bazil, V., Espevik, T., Finlay, B.B. and Wright, S.D., 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med., 176: 1665-1671.
29. Gianani, R. and Sarvetnick, N., 1996. Viruses, cytokines, antigens, and autoimmunity. Proc. Natl. Acad. Sci. USA, 93: 2257-2259.
30. George, A.J.T., 1994. Surface-bound cytokines - a possible effector mechanism in bacterial immunity. Immunol. Today, 15: 88-89.
31. Gooding, L.R., 1992. Viral proteins that counteract host immune defenses. Cell, 71: 5-7.
32. Gooding, L.R., 1994. Regulation of TNF-mediated cell death and inflammation by human adenoviruses. Infect. Agents Dis., 3: 106-115.
33. Grunwald, U., Kruger, C., Westerman, J., Lukowsky, A., Ehlers, M. and Schutt, C., 1994. An enzyme linked immunoassay for the quantification of solubilized CD14 in biological fluids. J. Immunol. Methods, 155: 225-232.
34. Haziot, A., Chen, S., Ferrero, E., Low, M.G., Silber, R. and Goyert, S.M., 1988. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol., 141: 547-552.
35. Haziot, A., Ferrero, E., Lin, X.Y., Stewart, C.L. and Goyert, S.M., 1995. CD14-deficient mice are exquisitely sensitive to the effects of LPS. In: J. Levin. C.R. Alving, R.S. Mumford and H. Redl (Eds.), Bacterial Endotoxins: Lipopolysaccharides from Genes to Therapy. Proc. of the Int. Endotoxin Soc. Wiley Liss, New York, p. 349-392.
36. Henderson, B. and Poole, S., 1994. Modulation of cytokine function: Therapeutic applications. Adv. Pharmacol., 25: 53-115.
37. Henderson, B. and Wilson, M., 1995. Modulins: A new class of cytokine-inducing, pro-inflammatory bacterial virulence factor. Inflamm. Res., 44: 187-197.
38. Henderson, B. and Wilson, M., 1996. Cytokine induction by bacteria: Beyond LPS. Cytokine, 8: 269-282.
39. Henderson, B. and Bodmer, M., 1996. Therapeutic Modulation of Cytokines. CRC Press, Boca Raton.
40. Henderson, B., Poole, S. and Wilson, M., 1996. Bacterial modulins: A novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev., 60, 316-341.
41. Henne, E., Campbell, W.H. and Carlson, E., 1991. Toxic shocksyndrome toxin 1 enhances synthesis of endotoxin-induced tumor necrosis factor in mice. Infect. Immun., 59: 2929-2933.
42. Hitchcock, P.J. and Morrison, D.C., 1984. The protein component of bacterial endotoxins. In: E.T. Rietschel (ed.), Handbook of Endotoxin, Vol. 1, Chemistry of Endotoxin. North Holland, Elsevier, pp. 339-375.
43. Hitchcock, P.J., Leive, L., Makeia, P.H., Rietschel, E.T., Strittmatter, W. and Morrison, D.C., 1986. Lipopolysaccharide nomenclature - past, present and future. J. Bacteriol., 166: 699-701.
44. Hoover, D.L., Friedlander, A.M., Rogers, L.C., Yoon, I-K., Warren, R.L. and Cross, A.S., 1994. Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect. Immun., 62: 4432-4439.
45. Houldsworth, S., Andrew, P.W. and Mitchell, T.J., 1994. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 β by human mononuclear phagocytes. Infect. Immun., 62: 1501-1503.
46. Hsu, D.H., de Waal Melefyt, R., Fiorentino, D.F., Dang, M.N., Viera, P., de Vries, J., Spits, H., Mosmann, T.R. and Moore, K.W., 1990. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science, 250: 830-832.
47. Hurley, J.C., 1993. Reappraisal of the role of endotoxin in the sepsis syndrome. Lancet, 341: 1133-1135.
48. Ibelgaufts, H., 1995. The Dictionary of Cytokines. VCH, Wein-heim.
49. Janeway, C.A., 1992. The immune system evolved to discriminate infectious nonself from non-infectious self. Immunol. Today, 13: 11-16.
50. Janeway, C.A., Travers, P., 1996. Immunobiology: The Immune System in Health and Disease, 2nd Ed. Blackwell, London.
51. Jiang, X. and Baldwin, C.L., 1993. Effects of cytokines on intracellular growth of Brucella abortus. Infect. Immun., 61: 124-134.
52. Kapur, V., Majesky, M.W., Li, L-L., Black, R.A. and Musser, J.M., 1993. Cleavage of interleukin-1 β (IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA, 90: 7676-7680.
53. Kaufmann, S.H.E. and Ladel, C.H., 1994. Application of knockout mice to the experimental analysis of infections with bacteria and protozoa. Trends Microbiol., 2: 235-242.
54. Kenny, B. and Finlay, B.B., 1995. Protein secretion by enteropathogenic Escherichia coli is essential for transducing signals to epithelial cells. Proc. Natl. Acad. Sci. USA, 92: 7991-7995.
55. Kharazmi, A., 1991. Mechanisms involved in the evasion of host defence by Pseudomonas aeruginosa. Immunol. Lett., 30: 201-205.
56. Kielian, T.L. and Blecha, F., 1995. CD14 and other recognition molecules for lipopolysaccharide: A review. Immunopharmacology, 29: 187-205.
57. Klaproth, J-M., Donnenberg, M.S., Abraham, J.M., Mobley, H.L.T. and James, S.P., 1995. Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect. Immun., 63: 2248-2254.
58. Komiyama, T.K., Ray, C.A., Pickup, D.J., Howard, A.D., Thornberry, N.A., Peterson, E.P. and Salvesen, G., 1994. Inhibition of interleukin-1 β converting enzyme by the cowpox virus serpin CrmA. J. Biol. Chem., 269: 19331-19337.
59. Konig, B. and Konig, W., 1993. Induction and suppression of cytokine release (TNF-alpha; IL-6; IL-1β) by E. coli pathogenicity factors (adhesins, alpha hemolysin). Immunology, 78: 526-533.
60. Konig, B., Ludwig, A., Goebel, W. and Konig, W., 1994. Pore formation by the Escherichia coli alpha hemolysin: Role for mediator release from human inflammatory cells. Infect. Immun., 62: 4611-4617.
61. Krieg, A.M., Yi, A-K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., Koretzky, G.A. and Klinman, D.M., 1995. CpG motifs in bacteria trigger direct B cell activation. Nature, 374: 546-549.
62. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. and Muller, W., 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 75: 253-261.
63. Kurita-Ochiai, T. and Ochiai, K., 1996. Immunosuppressive factor from Actinobacillus actinomycetemcomitans down-regulates cytokine production. Infect. Immun., 64: 50-54.
64. Kusunoki, T., Hailman, E., Juan, T.H-C., Lichtenstein, H.S. and Wright, S.D., 1995. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med., 182: 1673-1682.
65. Levine, D.M., Parker, T.S., Donelly, T.M., Walsh, A. and Rubin, A.L., 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA, 90: 12040-12044.
66. Lidbury, B.A., 1994. Theoretical article: Was exposure to directly antiviral cytokines during primary infection an important selective pressure in the evolution of unique immune evasion strategies of viruses? Immunol. Cell Biol., 72: 347-350.
67. Loppnow, H., Brade, H., Durrbaum, I. and Dinarello, C.A., 1989. IL-1 induction-capacity of defined lipopolysaccharide partial structures. J. Immunol., 142: 3229-3235.
68. Louise, C.B., Kaye, S.A., Boyd, B., Lingwood, C.A. and Obrig, T.G., 1991. Shiga toxin-associated hemolytic-uremic syndrome: Combined cytotoxic effects of Shiga toxin, interleukin-1 β, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun., 59: 4173-4179.
69. Luo, G., Niesel, D.W., Shaban, R.A., Grimm, E.A. and Klimple, G.R., 1993. Tumor necrosis factor alpha binding to bacteria: Evidence for a high affinity receptor and alterations of bacterial virulence properties. Infect. Immun., 61: 830-835.
70. Marchant, A., Vincent, J-L. and Goldman, M., 1996. Interleukin-10 as a protective cytokine produced during sepsis. In: D.C. Morrison and J.L. Ryan JL (Eds.), Novel Therapeutic Strategies in the Treatment of Sepsis. Marcel Dekker, New York, pp. 301-311.
71. Marrack, P. and Kappler, J., 1994. Subversion of the immune system by pathogens. Cell, 76: 323-332.
72. Matsiota-Bernard, P., Lefebre, C., Sedqui, M., Cornillet, P. and Guenounou, M., 1993. Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes. Infect. Immun., 61: 4980-4984.
73. Miller, D.K., 1996. Cytokine convertase inhibitors. In: B. Henderson and M. Bodmer (Eds.), Therapeutic Modulation of Cytokines. CRC Press, Boca Raton, pp. 143-170.
74. Mims, C.A., Dimmock, N.J., Nash, A. and Stephen, J., 1995. Mims' Pathogenesis of Infectious Disease, 4th Ed. Academic Press, London.
75. Mintz, C.S., Miller, R.D., Gutgsell, N.S. and Malek, T., 1993. Legionell pneumophila protease inactivates IL-2 and cleaves CD4 on human T cells. Infect. Immun., 61: 3416-3421.
76. Miyazaki, I., Cheung, R.K. and Dosch, H.M., 1993. Viral interleukin-10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J. Exp. Med., 178: 439-447.
77. Mizoguchi, A., Mizoguchi, E., Chiba, C., Spiekermann, G.M., Tonegawa, S., Nagler-Anderson, C. and Bhan, A.K., 1996. Cytokine imbalance and autoantibody production in T cell receptor-a mutant mice with inflammatory bowel disease. J. Exp. Med., 183: 847-856.
78. Morrison, D.C. and Lieve, L., 1975. Fractions of lipopolysaccharide from Escherichia coli 0111:B4 prepared by two extraction procedures. J. Biol. Chem., 250: 2911-2919.
79. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. and Coffman, R.L., 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol., 136: 2348-2357.
80. Mu, H-H. and Sewell, W.A., 1993. Enhancement of interleukin-4 production by pertussis toxin. Infect. Immun., 61: 2834-2840.
81. Munford, R.S., Hall, C.L. and Dietschy, J.M., 1981. Binding of Salmonella ryphimurium lipopolysaccharides to rat high-density lipoproteins. Infect. Immun., 34: 835-843.
82. Murphy, P.M., 1994. Molecular piracy of chemokine receptors by herpesviruses. Infect. Agents Dis., 3: 137-154.
83. Nair, S.P., Meghji, S., Wilson, M., Reddi, K., White, P.A. and Henderson, B., 1996. Bacterially-induced bone destruction: Mechanisms and misconceptions. Infect. Immun., 64, 2371-2380.
84. Netea, M.G., Demacker, P.N.M., Kullberg, B.J., Boerman, O.C., Verschueren, I., Stalenhoef, A.F.H. and van der Meer, J.W.M., 1996. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxaemia and severe Gram negative infections. J. Clin. Invest., 97: 1366-1372.
85. Neurath, A.R., Strick, N. and Sproul, P., 1992. Search for hepatitis B virus cell receptors reveals binding sites for interleukin-6 on the virus envelope protein, J. Exp. Med., 175: 461-469.
86. Otterlei, M., Varum, K.M., Ryan, L. and Espevik, T., 1994. Characterization of binding and TNFα-inducing ability of chitosans on monocytes: The involvement of CD14. Vaccine, 12: 825-832.
87. Palumbo, G.J., Buller, R.M. and Glasgow, W.C., 1994. Multigenic evasion of inflammation by poxviruses. J. Virol., 68: 1737-1749.
88. Parmely, M.P., Gale, A., Clabaugh, M., Horvat, R. and Zhou, W.W., 1990. Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect. Immun., 58: 3009-3014.
89. Patel, M.D., Henderson, B., Galgut, P. and Olsen, I., 1994. Mechanism of the anti-proliferative action of Actinobacillus actinomycetemcomitans surface-associated material. J. Dent. Res., 73: 793.
90. Peterson, P.K., Gekker, G., Hu, S., Sheng, W.S., Anderson, W.R., Ulevitch, R.J., Tobias, P.S., Gustafson, K.V., Molitor, T.W. and Chao, C.C., 1995. CD14 receptor uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun., 63: 1598-1602.
91. Pickup, D.J., 1994. Poxviral modifiers of cytokine responses to infection. Infect. Agents Dis., 3: 116-127.
92. Porat, R., Clark, B.D., Wolff, S.M. and Dinarello, C.A., 1991. Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science, 254: 430-432.
93. Pugin, J., Heumann, D., Tomasz, A., Kravchenko, V.V., Akamatsu, Y., Nishijima, M., Glauser, M.P., Tobias, P.A. and Ulevitch, R.J., 1994. CD14 is a pattern recognition receptor. Immunity, 1: 509-516.
94. Rahme, L.G., Stevens, E.J., Wolfort, S.F., Shao, J., Tompkins, R.G. and Ausubel, F.M., 1995. Common virulence factors for bacterial pathogenicity in plants and animals. Science, 268: 1899-1902.
95. Randow, F., Syrbe, U., Meisel, C., Krausch, D., Zuckerman, H., Platzer, C. and Volk, H-D., 1995. Mechanism of endotoxin desensitization: Involvement of interleukin-10 and transforming growth factor β. J. Exp. Med., 181: 1887-1892.
96. Rawadi, G. and Toman-Roman, S., 1996. Mycoplasma membrane lipoproteins induce proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect. Immun., 64: 637-643.
97. Ray, C.A., Black, R.A., Kronheim, S.R., Greenstreet, T.A., Sleath, P.R., Salvesen, G.S. and Pickup, D.J., 1992. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 β converting enzyme. Cell, 69: 597-604.
98. Reddi, K., Nair, S., White, P., Hodges, S., Tabona, P., Meghji, S., Poole, S., Wilson, M. and Henderson, B., 1996. Surface-associated material from the bacterium Actinobacillus actinomycetemcomitans contains a peptide which, in contrast to lipopolysaccharide, directly stimulates fibroblast interleukin-6 gene transcription. Eur. J. Biochem., 236: 871-876.
99. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A.C. and Horak, I., 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell, 75: 253-261.
100. Scales, W.E. and Kunkel, S.L., 1989. Regulatory interactions between interleukin-1, tumour necrosis factor, and other inflammatory mediators. In: R. Bomford and B. Henderson (Eds.), Interleukin-1: Inflammation and Disease. Elsevier, Amsterdam, pp. 163-172.
101. Shiratsuchi, H., Johnson, J.L. and Ellner, J.J., 1991. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J. Immunol., 146: 3165-3170.
102. Smith, G.L. and Chan, Y.S., 1991. Two vaccinia virus protein structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. J. Gen. Virol., 72: 511-518.
103. Smith, G.L., 1994. Virus strategies for the evasion of host response to infection. Trends Microbiol., 2: 81-88.
104. Smith, M.F., Eidlen, D., Arend, W.P. and Gutierrez-Hartman, A., 1994. LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J. Immunol., 153: 3584-3593.
105. Soell, M., Lett, F., Holveck, F., Scholler, M., Wachsmann, D. and Klein, J., 1995. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNFα release. J. Immunol., 154: 851-860.
106. Spriggs, M.K., Hruby, D.E., Maliszewski, C.R., Pickup, D.J., Sims, J.E., Buller, R.M.L. and VanSlyke, J., 1992. Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell, 71: 145-152.
107. Spriggs, M.K., 1994. Cytokine and cytokine receptor genes 'captured' by viruses. Curr. Opin. Immunol., 6: 526-529.
108. Stevens, D.L., 1994. Pathogenesis and immune response: Cellular interactions of virulence factors. Curr. Opin. Infect. Dis., 7: 285-286.
109. Takada, H. and Kotani, S., 1992. Structure-function relationships of lipid A. In: D.C. Morrison, J.L. Ryan, Bacterial Endototoxic Lipopolysaccharide, Vol. 1. CRC Press, Boca Raton, pp. 107-134
110. Tannock, G.W., 1995. Normal Microflora. Chapman and Hall, London.
111. Tesh, V.L., Ramegowda, B. and Samuel, J.E., 1994. Purified Shiga-like toxins induce expression of pro-inflammatory cytokines from murine peritoneal macrophages. Infect. Immun., 62: 5085-5094.
112. Treseler, C.B., Maziarz, R.T. and Levitz, S.M., 1992. Biological activity of interleukin-2 bound to Candida albicans. Infect. Immun., 60: 183-188.
113. Tsukada, H., Kawamura, I., Fujimura, T., Igarashi, K-I., Arakawa, M. and Mitsuyama, M., 1992. Induction of macrophage interleukin-1 production by Listeria monocytogenes hemolysin. Cell Immunol., 140: 21-30.
114. Van der Kar, N.C.A.J., Monnens, L.A.H., Karmali, M.A. and van Hinsbergh, V.W.M., 1992. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: Implications for the pathogenesis of the hemolytic uremic syndrome. Blood, 80: 2755-2764.
115. Weber-Nordt, R.M., Meraz, M.A. and Schreiber, R.D., 1994. Lipopolysaccharide-dependent induction of IL-10 receptor expression on murine fibroblasts. J. Immunol., 153: 3734-3744.
116. Weidemann, B., Brade, H., Rietschel, E.T., Dziarski, R., Bazil, V., Kusumoto, S., Flad, H. and Ulmer, A.J., 1994. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect. Immun., 62: 4709-4715.
117. Westphal, O. and Jann, K., 1965. Bacterial lipopolysaccharide. Extraction with phenol-water and further application of the procedure. Meth. Carbohydr. Chem., 15: 83-91.
118. Westphal, O., Luderitz, O. and Bister, F., 1952. Uber die Extraktion von Bakterien mit Phenol/Wasser. Z. Naturforsch., 7: 148-156.
119. Wilson, M. and Henderson, B., 1995. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. FEMS Microbiol. Rev., 17: 365-379.
120. White, P.A., Wilson, M., Nair, S.P., Kirby, A.C., Reddi, K. and Henderson, B., 1995. Characterization of an anti-proliferative surface-associated protein from Actinobacillus actinomycetemcomitans which can be neutralized by sera from a proportion of patients with localized juvenile periodontitis. Infect. Immun., 63: 2612-2618
121. Wright, S.D., 1995. CD14 and innate recognition of bacteria. J. Immunol., 155: 608.
122. Wright, S.D., Ramos, R., Tobias, P.S., Ulevitch, R.J. and Mathison, J.C., 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science, 249: 1431-1435.
123. Wright, S.D., Ramos, R., Hermanowski-Vosatka, A., Rockwell, P. and Detmers, P.A., 1991. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: Dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med., 173: 1281-1286.
124. Wurfel, M.M., Heilman, E. and Wright, S.D., 1995. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med., 181: 1743-1754.
125. Yoshikawa, H., Kawamura, I., Fujita, M., Tsukada, H., Arakawa, M. and Mitsuyama, M., 1993. Membrane damage and interleukin-1 production in murine macrophages exposed to listeriolysin O. Infect. Immun., 61: 1334-1339.
126. Zhang, Y., Doerfler, M., Lee, T.C., Guillemin, B. and Rom, W.M., 1993. Mechanisms of stimulation of interleukin-1 β and tumor necrosis factor alpha by Mycobacterium tuberculosis components. J. Clin. Invest., 91: 2076-2083.